Tiago Torres (T Torres)

ResearcherID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 94

Top Venues

American journal of clinical dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Pharmaceutics

Dermatology and therapy

Centro Hospitalar do Porto

Instituto de Ciências Biomédicas Abel Salazar (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro Hospitalar do Porto Apr 01 2006

Portugal

MD, PhD :: Dermatology

Education History

Instituto de Ciências Biomédicas Abel Salazar Nov 19 2014

Portugal

PHD :: Dermatology

Publications

Tiago Torres, Andrea Chiricozzi, Luis Puig, Ana Maria Lé, Angelo Valerio Marzano, Paolo Dapavo, Esteban Dauden, Jόse-Manuel Carrascosa, Elizabeth Lazaridou, Gleison Duarte, André V E Carvalho, Ricardo Romiti, Natalia Rompoti, Laetitia Teixeira, Miguel Abreu, Elena Ippoliti, Carlo Alberto Maronese, Mar Llamas-Velasco, Eva Vilarrasa, Elena Del Alcázar, Athina-Ioanna Daponte, Marina Papoutsaki, Andrea Carugno, Francesco Bellinato, Paolo Gisondi
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. American journal of clinical dermatology 25 (2) (2024)
Tomás Estevinho, Egídio Freitas, Tiago Torres
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV. The Journal of international medical research 52 (3) (2024)
Tiago Torres, Joana Antunes, Ana Brasileiro, João Alves, Diana Bernardo, José Ramos, Diogo Sousa, Cristina Castro, Ana Gusmão Palmeiro, André Aparício Martins, Joana Fazendeiro Matos, Bárbara Vieira Granja, Pedro Ponte, Gabriela Marques Pinto, Paula Quirino, Francisco Menezes Brandão, Laetitia Teixeira, Sofia Magina, Maria João Paiva Lopes, Hugo Oliveira, Paulo Varela, João Telles Sousa, Paulo Filipe, Rui Tavares Bello
Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study. The Journal of dermatological treatment 35 (1) (2024)
Orhan Yilmaz, João Pedro Pinto, Tiago Torres
New and emerging oral therapies for psoriasis. Drugs in context 13 (2024)
Stefanie Ziehfreund, Hannah Wecker, S Mittag, J Weis, Linda Tizek, V Verkhoturova, Franz Josef Legat, W Weger, Katja Großschädl, U Cerpes, Birgit Sadoghi, M Riegler, A Balato, Eugenia Veronica Di Brizzi, Dario Buononato, Graziella Babino, P Calzavara-Pinton, M T Rossi, S Rovaris, A Dimech, M J Boffa, Pavel Viktorovich Chernyshov, T Svyatenko, L Kolodzinska, M Sikora, Tiago Torres, L Manolache, Emanuele Scala, T Biedermann, Alexander Zink
Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Hannah Wecker, Stefanie Ziehfreund, Sebastian Sitaru, Emma K Johansson, Jesper Elberling, Anaïs Doll, Electra Nicolaidou, Emanuele Scala, Michael J Boffa, Lea Schmidt, Mariusz Sikora, Tiago Torres, Pavel Viktorovich Chernyshov, Alexander Zink
Burden of atopic dermatitis in Europe: A population-centred approach leveraging web search data in 21 European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Ana Teixeira, Maribel Teixeira, Ana Rita Gaio, Tiago Torres, Sofia Magina, Maria Alzira Pimenta Dinis, José Manuel Sousa Lobo, Isabel Filipa Almeida, Miguel Peixoto, Vera Almeida
Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis. Healthcare (Basel, Switzerland) 12 (8) (2024)
Tomás Estevinho, Egídio Freitas, Tiago Torres
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV. The Journal of international medical research 52 (3) (2024)
Tomás Estevinho, Egídio Freitas, Tiago Torres
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV. The Journal of international medical research 52 (3) (2024)
Ana Teixeira, Maribel Teixeira, Ana Rita Gaio, Tiago Torres, Sofia Magina, Maria Alzira Pimenta Dinis, José Manuel Sousa Lobo, Isabel Filipa Almeida, Miguel Peixoto, Vera Almeida
Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis. Healthcare (Basel, Switzerland) 12 (8) (2024)
Hannah Wecker, Stefanie Ziehfreund, Sebastian Sitaru, Emma K Johansson, Jesper Elberling, Anaïs Doll, Electra Nicolaidou, Emanuele Scala, Michael J Boffa, Lea Schmidt, Mariusz Sikora, Tiago Torres, Pavel Viktorovich Chernyshov, Alexander Zink
Burden of atopic dermatitis in Europe: A population-centred approach leveraging web search data in 21 European countries. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Anastasia Drakos, Tiago Torres, Ronald B Vender
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics 16 (1) (2024)
Tiago Torres, Anne Sohrt, Ulla Ivens, Albert Bosch Vilaro, John Stinson, Y José Manuel Carrascosa
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy 14 (4) (2024)
Tiago Torres, Andrea Chiricozzi, Luis Puig, Ana Maria Lé, Angelo Valerio Marzano, Paolo Dapavo, Esteban Dauden, Jόse-Manuel Carrascosa, Elizabeth Lazaridou, Gleison Duarte, André V E Carvalho, Ricardo Romiti, Natalia Rompoti, Laetitia Teixeira, Miguel Abreu, Elena Ippoliti, Carlo Alberto Maronese, Mar Llamas-Velasco, Eva Vilarrasa, Elena Del Alcázar, Athina-Ioanna Daponte, Marina Papoutsaki, Andrea Carugno, Francesco Bellinato, Paolo Gisondi
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. American journal of clinical dermatology 25 (2) (2024)
João Vilaça, Orhan Yilmaz, Tiago Torres
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors. Pharmaceutics 16 (7) (2024)
Anastasia Drakos, Tiago Torres, Ronald B Vender
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics 16 (1) (2024)
Orhan Yilmaz, João Pedro Pinto, Tiago Torres
New and emerging oral therapies for psoriasis. Drugs in context 13 (2024)
Tiago Torres, Maria João Cruz, Margarida Gonçalo, Paulo Filipe, Bruno Duarte, João Alves, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, Alberto Mota, Maria João Paiva Lopes
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study. Dermatology and therapy (2024)
Hannah Wecker, Stefanie Ziehfreund, Sebastian Sitaru, Emma K Johansson, Jesper Elberling, Anaïs Doll, Electra Nicolaidou, Emanuele Scala, Michael J Boffa, Lea Schmidt, Mariusz Sikora, Tiago Torres, Pavel Viktorovich Chernyshov, Alexander Zink
Burden of atopic dermatitis in Europe: A population-centred approach leveraging web search data in 21 European countries. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (8) (2024)
Tiago Torres, Maria João Cruz, Margarida Gonçalo, Paulo Filipe, Bruno Duarte, João Alves, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, Alberto Mota, Maria João Paiva Lopes
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study. Dermatology and therapy 14 (8) (2024)
Andrea Chiricozzi, Giulia Coscarella, Lluis L Puig, Ronald B Vender, Jensen Yeung, Y José Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, Charles Lynde, Paulo Ferreira, Pedro Mendes Bastos, Esteban Daudén, Luiz Leite, Joana Valerio, Elena Del Alcázar-Viladomiu, Eva Vilarrasa, Mar Llamas Velasco, Mario Alessandri-Bonetti, Francesco Messina, Manfredo Bruni, Eugenia Veronica Di Brizzi, Federica Ricceri, Alessia Nidegger, Jan Hugo, Asfandyar Mufti, Athina-Ioanna Daponte, Laetitia Teixeira, Anna Balato, Marco Romanelli, Francesca Prignano, Spyridon Gkalpakiotis, Curdin Conrad, Elizabeth Lazaridou, Natalia Rompoti, Alexander J Stratigos, Miguel Nogueira, Ketty Peris, Tiago Torres
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
João Vilaça, Orhan Yilmaz, Tiago Torres
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors. Pharmaceutics 16 (7) (2024)
Tiago Torres, Anne Sohrt, Ulla Ivens, Albert Bosch Vilaro, John Stinson, Y José Manuel Carrascosa
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy 14 (4) (2024)
Tiago Torres, Andrea Chiricozzi, Luis Puig, Ana Maria Lé, Angelo Valerio Marzano, Paolo Dapavo, Esteban Dauden, Jόse-Manuel Carrascosa, Elizabeth Lazaridou, Gleison Duarte, André V E Carvalho, Ricardo Romiti, Natalia Rompoti, Laetitia Teixeira, Miguel Abreu, Elena Ippoliti, Carlo Alberto Maronese, Mar Llamas-Velasco, Eva Vilarrasa, Elena Del Alcázar, Athina-Ioanna Daponte, Marina Papoutsaki, Andrea Carugno, Francesco Bellinato, Paolo Gisondi
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. American journal of clinical dermatology 25 (2) (2024)
Tiago Torres, Joana Antunes, Ana Brasileiro, João Alves, Diana Bernardo, José Ramos, Diogo Sousa, Cristina Castro, Ana Gusmão Palmeiro, André Aparício Martins, Joana Fazendeiro Matos, Bárbara Vieira Granja, Pedro Ponte, Gabriela Marques Pinto, Paula Quirino, Francisco Menezes Brandão, Laetitia Teixeira, Sofia Magina, Maria João Paiva Lopes, Hugo Oliveira, Paulo Varela, João Telles Sousa, Paulo Filipe, Rui Tavares Bello
Clinical course and disease burden of patients with generalized pustular psoriasis in Portugal: a multicenter retrospective cohort study. The Journal of dermatological treatment 35 (1) (2024)
Tiago Torres, Maria João Cruz, Margarida Gonçalo, Paulo Filipe, Bruno Duarte, João Alves, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, Alberto Mota, Maria João Paiva Lopes
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study. Dermatology and therapy 14 (8) (2024)
Anastasia Drakos, Tiago Torres, Ronald B Vender
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents. Pharmaceutics 16 (1) (2024)
Tiago Torres, Andrea Chiricozzi, Luis Puig, Ana Maria Lé, Angelo Valerio Marzano, Paolo Dapavo, Esteban Dauden, Jόse-Manuel Carrascosa, Elizabeth Lazaridou, Gleison Duarte, André V E Carvalho, Ricardo Romiti, Natalia Rompoti, Laetitia Teixeira, Miguel Abreu, Elena Ippoliti, Carlo Alberto Maronese, Mar Llamas-Velasco, Eva Vilarrasa, Elena Del Alcázar, Athina-Ioanna Daponte, Marina Papoutsaki, Andrea Carugno, Francesco Bellinato, Paolo Gisondi
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. American journal of clinical dermatology 25 (2) (2024)
Tiago Torres, Anne Sohrt, Ulla Ivens, Albert Bosch Vilaro, John Stinson, Y José Manuel Carrascosa
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy 14 (4) (2024)
João Vilaça, Orhan Yilmaz, Tiago Torres
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors. Pharmaceutics 16 (7) (2024)
Tiago Torres, Paulo Varela, Pedro Mendes Bastos, Sofia Magina, Martinha Henrique, Paulo Ferreira
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study. Drugs in context 13 (2024)
Ana Teixeira, Maribel Teixeira, Ana Rita Gaio, Tiago Torres, Sofia Magina, Maria Alzira Pimenta Dinis, José Manuel Sousa Lobo, Isabel Filipa Almeida, Miguel Peixoto, Vera Almeida
Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis. Healthcare (Basel, Switzerland) 12 (8) (2024)
Tiago Torres, Anne Sohrt, Ulla Ivens, Albert Bosch Vilaro, John Stinson, Y José Manuel Carrascosa
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy (2024)
Orhan Yilmaz, Tiago Torres
Extended Half-life Antibodies: A Narrative Review of a New Approach in the Management of Atopic Dermatitis. Dermatology and therapy (2024)
Tiago Torres, Maria João Cruz, Margarida Gonçalo, Paulo Filipe, Bruno Duarte, João Alves, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, Alberto Mota, Maria João Paiva Lopes
Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study. Dermatology and therapy 14 (8) (2024)
Tiago Torres, N C Brembilla, R G Langley, R B Warren, D Thaçi, A G A Kolios, Jörg C Prinz, A Londono-Garcia, Alexander Nast, M Santin, D Goletti, M Abreu, P Spuls, W H Boehncke, Lluis L Puig
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Tiago Torres, Andrea Chiricozzi, Luis Puig, Ana Maria Lé, Angelo Valerio Marzano, Paolo Dapavo, Esteban Dauden, Jόse-Manuel Carrascosa, Elizabeth Lazaridou, Gleison Duarte, André V E Carvalho, Ricardo Romiti, Natalia Rompoti, Laetitia Teixeira, Miguel Abreu, Elena Ippoliti, Carlo Alberto Maronese, Mar Llamas-Velasco, Eva Vilarrasa, Elena Del Alcázar, Athina-Ioanna Daponte, Marina Papoutsaki, Andrea Carugno, Francesco Bellinato, Paolo Gisondi
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study. American journal of clinical dermatology (2024)
Tiago Torres, Paulo Varela, Pedro Mendes Bastos, Sofia Magina, Martinha Henrique, Paulo Ferreira
Tildrakizumab for the treatment of moderate-to-severe psoriasis: a 52-week, real-world Portuguese multicentric study. Drugs in context 13 (2024)
Tiago Torres, Anne Sohrt, Ulla Ivens, Albert Bosch Vilaro, John Stinson, Y José Manuel Carrascosa
Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy 14 (4) (2024)
A Reymundo, S Armesto, L Rodríguez, O Baniandrés, A Sahuquillo-Torralba, Tiago Torres, P de la Cueva, M Llamas-Velasco, E Daudén
Effectiveness of Secukinumab for the treatment of erythrodermic psoriasis. Multicenter study in daily practice. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Dea Metko, Tiago Torres, Ronald B Vender
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators? The Journal of international medical research 51 (6) (2023)
Egídio Freitas, Maria João Paiva Lopes, Maria João Cruz, Diogo Sousa, Ana Clara Valente, Bruno Duarte, Laetitia Teixeira, Gilberto Rosas, Mónica Caetano, Alberto Mota, Paulo Filipe, Tiago Torres
Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis. Clinical drug investigation 44 (1) (2023)
Egídio Freitas, Tiago Torres
Difamilast for the treatment of atopic dermatitis. The Journal of international medical research 51 (6) (2023)
Egídio Freitas, Emma Guttman-Yassky, Tiago Torres
Baricitinib for the Treatment of Alopecia Areata. Drugs (2023)
Diana Bernardo, Thomas Bieber, Tiago Torres
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis. American journal of clinical dermatology (2023)
Diana Bernardo, Diamant Thaçi, Tiago Torres
Spesolimab for the Treatment of Generalized Pustular Psoriasis. Drugs 84 (1) (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, Y José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and therapy (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy (2023)
Ana Maria Lé, Melinda J Gooderham, Tiago Torres
Abrocitinib for the treatment of atopic dermatitis. Immunotherapy (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Adam Reich, Andreas Pinter, Julia-Tatjana Maul, Ronald B Vender, Tiago Torres, A Brnabic, Natalie Haustrup, C Reed, C Schuster, E Riedl
Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
S Skrek, V Di Lernia, A Beauchet, A-C Bursztejn, Anna Belloni Fortina, A Lesiak, J Thomas, Piotr Brzezinski, Z Topkarci, N Murashkin, Tiago Torres, R Epishev, Anca E Chiriac, T McPherson, M Akinde, Annabel Maruani, P C Luna, H Vidaurri de la Cruz, S Mallet, S Leducq, M Sergeant, J Zitouni, S K Mahil, Catherine H Smith, Carsten Flohr, H Bachelez, E Mahé, null null
Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Egídio Freitas, Maria João Paiva Lopes, Maria João Cruz, Diogo Sousa, Ana Clara Valente, Bruno Duarte, Laetitia Teixeira, Gilberto Rosas, Mónica Caetano, Alberto Mota, Paulo Filipe, Tiago Torres
Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis. Clinical drug investigation (2023)
Diana Bernardo, Diamant Thaçi, Tiago Torres
Spesolimab for the Treatment of Generalized Pustular Psoriasis. Drugs (2023)
Diana Bernardo, Diamant Thaçi, Tiago Torres
Spesolimab for the Treatment of Generalized Pustular Psoriasis. Drugs 84 (1) (2023)
Diogo Fonseca, Miguel Nogueira, Tiago Torres
Upadacitinib for the treatment of psoriatic arthritis. Drugs in context 12 (2023)
Adam Reich, Andreas Pinter, Julia-Tatjana Maul, Ronald B Vender, Tiago Torres, A Brnabic, Natalie Haustrup, C Reed, C Schuster, E Riedl
Speed of Clinical Improvement in the Real-World Setting from Patient-Reported Psoriasis Symptoms and Signs Diary (PSSD): Secondary Outcomes from the Psoriasis Study of Health Outcomes (PSoHO) Through 12 Weeks. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Egídio Freitas, Maria João Paiva Lopes, Maria João Cruz, Diogo Sousa, Ana Clara Valente, Bruno Duarte, Laetitia Teixeira, Gilberto Rosas, Mónica Caetano, Alberto Mota, Paulo Filipe, Tiago Torres
Real-World Effectiveness and Safety of Baricitinib in Patients with Atopic Dermatitis. Clinical drug investigation 44 (1) (2023)
Sofia Faria, Egídio Freitas, Tiago Torres
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date. Drugs in context 12 (2023)
Diana Bernardo, Diamant Thaçi, Tiago Torres
Spesolimab for the Treatment of Generalized Pustular Psoriasis. Drugs 84 (1) (2023)
Andrea Chiricozzi, S M Ferrucci, L Di Nardo, N Gori, A Balato, M Ortoncelli, Martina Maurelli, Marco Galluzzo, M Munera Campos, T Seremet, Giacomo Caldarola, C De Simone, E Ippoliti, Tiago Torres, S Gkalpakiotis, C Conrad, J M Carrascosa, L Bianchi, G Argenziano, S Ribero, G Girolomoni, A V Marzano, K Peris, null null
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study. Expert opinion on biological therapy 23 (12) (2023)
Egídio Freitas, Emma Guttman-Yassky, Tiago Torres
Baricitinib for the Treatment of Alopecia Areata. Drugs (2023)
Anastasia Drakos, Ronald B Vender, Tiago Torres
Topical roflumilast for the treatment of psoriasis. Expert review of clinical immunology (2023)
Diana Bernardo, Diamant Thaçi, Tiago Torres
Spesolimab for the Treatment of Generalized Pustular Psoriasis. Drugs 84 (1) (2023)
Diogo Fonseca, Miguel Nogueira, Tiago Torres
Upadacitinib for the treatment of psoriatic arthritis. Drugs in context 12 (2023)
Ana Maria Lé, Lluis L Puig, Tiago Torres
Deucravacitinib for the Treatment of Psoriatic Disease. American journal of clinical dermatology 23 (6) (2022)
J Zitouni, A-C Bursztejn, Anna Belloni Fortina, A Beauchet, V Di Lernia, A Lesiak, J Thomas, Z Topkarci, N Murashkin, Piotr Brzezinski, Tiago Torres, Anca E Chiriac, C Luca, T McPherson, M Akinde, A Maruani, R Epishev, H Vidaurri de la Cruz, P C Luna, M Amy de la Bretêque, A Lasek, E Bourrat, M Bachelerie, S Mallet, M Steff, A Bellissen, I Neri, Efterpi Zafiriou, J M P A van den Reek, Enikö Sonkoly, S K Mahil, Catherine H Smith, Carsten Flohr, H Bachelez, Emmanuel Mahé, null null
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry). Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Ana Maria Lé, Tiago Torres
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab. Pharmaceutics 14 (12) (2022)
Katie Bechman, Emma S Cook, Nick Dand, Zenas Zee Ngai Yiu, Teresa Tsakok, Freya Meynell, Bolaji Coker, Alexandra Vincent, Herve Bachelez, Ines Barbosa, Matthew A Brown, Francesca Capon, Claudia R Contreras, Claudia De La Cruz, Paola Di Meglio, Paolo Gisondi, Denis Jullien, Jade Kelly, Jo Lydie Wilfried Lambert, Camille Lancelot, Sinéad M Langan, Kayleigh J Mason, Helen McAteer, Lucy Moorhead, Luigi Naldi, Katherine Jones, Lluis L Puig, Phyllis I Spuls, Tiago Torres, Dominic Urmston, Amber Vesty, Richard Bruce Warren, Hoseah Waweru, John Weinman, Christopher Ernest Maitland Griffiths, Jonathan N W N Barker, Catherine H Smith, James B Galloway, Satveer K Mahil, null null
Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. The British journal of dermatology 187 (2) (2022)
Ana Maria Lé, Tiago Torres
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab. Pharmaceutics 14 (12) (2022)
Egídio Freitas, Melinda Gooderham, Tiago Torres
New Topical Therapies in Development for Atopic Dermatitis. Drugs 82 (8) (2022)
Matthias Augustin, P G Sator, R von Kiedrowski, Curdin Conrad, Dimitrios Rigopoulos, Marco Romanelli, P-D Ghislain, Tiago Torres, Demetrios Ioannides, M Aassi, B Schulz, P Jagiello, null null
Secukinumab demonstrated sustained retention, effectiveness and safety in a real-world setting in patients with moderate-to-severe plaque psoriasis: long-term results from an interim analysis of the SERENA study. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Ana Maria Lé, Tiago Torres
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab. Pharmaceutics 14 (12) (2022)
Ana Maria Lé, Tiago Torres
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab. Pharmaceutics 14 (12) (2022)
Sofia Nogueira, Maria Alexandra Rodrigues, Ron Vender, Tiago Torres
Tapinarof for the treatment of psoriasis. Dermatologic therapy (2022)
Tomás Estevinho, Ana Maria Lé, Tiago Torres
Deucravacitinib in the treatment of psoriasis. The Journal of dermatological treatment (2022)
Tiago Torres, Luis Puig, Ron Vender, Jensen Yeung, José-Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, Charles Lynde, Paulo Ferreira, Pedro Mendes Bastos, Esteban Dauden, Luiz Leite, Joana Valerio, Elena Del Alcázar-Viladomiu, Eva Vilarrasa Rull, Mar Llamas-Velasco, Federico Pirro, Francesco Messina, Manfredo Bruni, Gaetano Licata, Federica Ricceri, Alessia Nidegger, Jan Hugo, Asfandyar Mufti, Athina-Ioanna Daponte, Laetitia Teixeira, Anna Balato, Marco Romanelli, Francesca Prignano, Spyridon Gkalpakiotis, Curdin Conrad, Elizabeth Lazaridou, Natalia Rompoti, Marina Papoutsaki, Miguel Nogueira, Andrea Chiricozzi
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study. American journal of clinical dermatology 23 (6) (2022)
Ana Maria Lé, Tiago Torres
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab. Pharmaceutics 14 (12) (2022)
Tiago Torres, Marta Pereira, Maria João Paiva Lopes, Clarisse Rebelo, Pedro Andrade, Martinha Henrique, Hugo Oliveira, Paulo Ferreira, Gabriela Marques Pinto, Francisco Menezes Brandão, Jorge Rozeira, Paulo Filipe, Rui Tavares Bello
Dermatologists' attitude towards psoriasis treatment during the COVID-19 pandemic. Drugs in context 10 (2021)
Egídio Freitas, Andrew Blauvelt, Tiago Torres
Bimekizumab for the Treatment of Psoriasis. Drugs 81 (15) (2021)
S K Mahil, M Yates, S M Langan, Z Z N Yiu, T Tsakok, N Dand, Kayleigh J Mason, H McAteer, F Meynell, B Coker, A Vincent, D Urmston, A Vesty, J Kelly, C Lancelot, L Moorhead, Herve Bachelez, I N Bruce, Francesca Capon, C R Contreras, A P Cope, C De La Cruz, Paola Di Meglio, Paolo Gisondi, K Hyrich, D Jullien, J Lambert, H Marzo-Ortega, I McInnes, L Naldi, S Norton, Lluis L Puig, R Sengupta, P Spuls, Tiago Torres, R B Warren, H Waweru, J Weinman, C E M Griffiths, J N Barker, M A Brown, J B Galloway, C H Smith, null null
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. The British journal of dermatology 185 (1) (2021)
Egídio Freitas, Emma Guttman-Yassky, Tiago Torres
Tralokinumab for the Treatment of Atopic Dermatitis. American journal of clinical dermatology 22 (5) (2021)
Tiago Torres, Luis Puig, Ron Vender, Charles Lynde, Stefano Piaserico, Jose M Carrascosa, Paolo Gisondi, Esteban Daudén, Curdin Conrad, Pedro Mendes-Bastos, Paulo Ferreira, Luiz Leite, Justin D Lu, J Valerio, M Bruni, F Messina, A Nidegger, M Llamas-Velasco, E Del Alcazar, A Mufti, Kyra White, G Caldarola, Laetitia Teixeira, Paolo Romanelli, K Desai, Spyridon Gkalpakiotis, Marco Romanelli, Jensen Yeung, Miguel Nogueira, Andrea Chiricozzi
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study. American journal of clinical dermatology 22 (4) (2021)
Bárbara Leal, Cláudia Carvalho, Ana Marta Ferreira, Miguel Nogueira, Sandra Brás, Berta M Silva, Manuela Selores, Paulo P Costa, Tiago Torres
Serum Levels of miR-146a in Patients with Psoriasis. Molecular diagnosis & therapy 25 (4) (2021)
Tiago Torres, Andrea Chiricozzi, Luis Puig
Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study". American journal of clinical dermatology 22 (6) (2021)
Ana Maria Lé, Tiago Torres
New Topical Therapies for Psoriasis. American journal of clinical dermatology (2021)
Miguel Nogueira, Amy S Paller, Tiago Torres
Targeted Therapy for Pediatric Psoriasis. Paediatric drugs 23 (3) (2021)
Daniel G Oliveira, Raquel Faria, Tiago Torres
An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so Far. Drug design, development and therapy 15 (2021)
Sandra Ferreira, Emma Guttman-Yassky, Tiago Torres
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib. American journal of clinical dermatology 21 (6) (2021)
Egídio Freitas, Maria Alexandra Rodrigues, Tiago Torres
Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations. Clinical, cosmetic and investigational dermatology 13 (2020)
Miguel Nogueira, Lluis L Puig, Tiago Torres
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors. Drugs 80 (4) (2020)
M Nogueira, R B Warren, Tiago Torres
Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm change. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (4) (2020)
Tiago Torres, Lluis L Puig
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic. American journal of clinical dermatology 21 (3) (2020)

Tiago Torres.css-eqlu8i{font-size:small;padding-left:4px;} (T Torres)

Publication Activity (10 Years)

Top Topics

Top Venues

Tiago Torres (T Torres)